Fierro-Arias L, Barrera-Pérez M, Portilla-Demichelis A

Language: Spanish
References: 18
Page: 59-33
PDF size: 226.53 Kb.

ABSTRACT

The use of treatments with exogenous substances (called filling materials or fillers) for therapeutic purposes in facial cosmetics, is increasingly common in different medical specialties. One of the infrequent, but possible complications is occlusion by embolus in arteries of structures near the infiltration site; in this event, the possibility of blocking ocular irrigation has been reported, and the consequence can be as serious as iatrogenic blindness. The purpose of this review is to present the measures recommended in the current literature, to execute immediate maneuvers in order to reestablishment the ocular perfusion, avoiding irreversible damage to visual function.

REFERENCES

1. Barbarino S, Banker T y Fezza J., Standardized approach to treatmentof retinal artery occlusion after intraarterial injection of soft tissue fillers:eye-code, J Am Acad Dermatol 2022; 86(5):1102-8.

2. Loh KT, Chua JJ, Lee HM et al., Prevention and management of visionloss relating to facial filler injections, Singapore Med J 2016; 57(8):438-43.

3. Chatrath V, Banerjee PS, Goodman GJ y Rahman E, Soft-tissue fillerassociatedblindness: a systematic review of case reports and case series,Plast Reconstr Surg Glob Open 2019; 7(4):e2173.

4. Walker L y King M, This month’s guideline: visual loss secondary tocosmetic filler injection, J Clin Aesthet Dermatol 2018; 11(5):e53-5.

5. Joganathan V y Shah-Desai S, Awareness of management of hyaluronicacid induced visual loss: a British National Survey, Eye (Londres)2020; 34(12):2280-3. doi: 10.1038/s41433-020-0810-7.

6. Humzah MD, Ataullah S, Chiang C et al., The treatment of hyaluronicacid aesthetic interventional induced visual loss (aii vl): a consensus onpractical guidance, J Cosmet Dermatol 2019; 18(1):71-6.

7. Carruthers JDA, Fagien S, Rohrich RJ et al., Blindness caused by cosmeticfiller injection: a review of cause and therapy, Plast Reconstr Surg2014; 134(6):1197-201.

8. Tran AQ y Lee WW, Vision loss and blindness following fillers, J DermatolSkin Sci 2021; 3(2):1-4.

9. Vargas-Laguna E, García-Gavín J y Bárcena-Ruiz E. Safety in dermatologicprocedures: vascular occlusion by filling materials, Actas Dermosifiliogr2021. doi: 10:S0001-7310(21)00177-0.

10. Hwang CJ, Morgan PV, Pimentel A et al., Rethinking the role of nitroglycerinointment in ischemic vascular filler complications: an animalmodel with icg imaging, Ophthalmic Plast Reconstr Surg 2016; 32(2):118-22.

11. Murthy R, Roos JCP y Goldberg RA, Periocular hyaluronic acid fillers:applications, implications, complications, Curr Opin Ophthalmol 2019;30(5):395-400.

12. Beleznay K, Carruthers JD, Humphrey S y Jones D, Avoiding and treatingblindness from fillers: a review of the world literature, DermatolSurg 2015; 41(10):1097-117.

13. Zhu GZ, Sun ZS, Liao WX et al., Efficacy of retrobulbar hyaluronidaseinjection for vision loss resulting from hyaluronic acid filler embolization,Aesthet Surg J 2017; 38(1):12-22.

14. Kapoor KM, Murthy R, Hart SLA et al., Factors influencing pre-injectionaspiration for hyaluronic acid fillers: a systematic literature reviewand meta-analysis, Dermatol Ther 2021; 34(1):e14360.

15. Prado G y Rodríguez-Feliz J, Ocular pain and impending blindnessduring facial cosmetic injections: is your office prepared?, AestheticPlast Surg 2017; 41(1):199-203.

16. Lee W, Koh IS, Oh W y Yang EJ, Ocular complications of soft tissuefiller injections: a review of literature, J Cosmet Dermatol 2020;19(4):772-81.

17. Lacerda D, Prevention and management of iatrogenic blindness associatedwith aesthetical filler injections, Dermatol Ther 2018; 31(6):e12722.

18. Kapoor KM, Kapoor P, Heydenrych I y Bertossi D, Vision loss associatedwith hyaluronic acid fillers: a systematic review of literature,Aesthetic Plast Surg 2020; 44(3):929-44.